Skip to main content
  • About Us
  • News
  • Careers
  • Authorized Partners
  • Products
  • Conditions
  • Education & Events
  • Value-based solutions
  • Support
  • Careers
  • News

W. L. GORE & ASSOCIATES LAUNCHES GORE® SYNECOR PREPERITONEAL BIOMATERIAL IN EUROPE, THE MIDDLE EAST AND SOUTH AFRICA

Apr 2, 2025

W. L. GORE & ASSOCIATES, INC. RECEIVES CE MARK FOR LOWER PROFILE GORE® VIABAHN® VBX BALLOON EXPANDABLE ENDOPROSTHESIS, NOW 6 FR SHEATH COMPATIBLE

Jan 13, 2025

FIRST EUROPEAN IMPLANTATION OF GORE® TAG® THORACIC BRANCH ENDOPROSTHESIS

Feb 1, 2024

FIRST PATIENTS ENROLLED IN THE GORE VBX FORWARD CLINICAL STUDY

Jan 16, 2024

GORE INITIATES STUDY TO EVALUATE GORE® VIABAHN® VBX BALLOON EXPANDABLE ENDOPROSTHESIS AS BRIDGING STENT

Feb 16, 2023

GORE COMPLETES ENROLLMENT IN THE GORE® VIABAHN® VBX BALLOON EXPANDABLE ENDOPROSTHESIS EXPAND REGISTRY

This registry will confirm safety and performance of the VBX Stent Graft in peripheral vessels in patients who require interventional treatment in a variety of applications and diseases.

Oct 27, 2022

GORE MEDICAL RECEIVES BREAKTHROUGH DEVICE DESIGNATION FOR THE GORE® EXCLUDER® THORACOABDOMINAL BRANCH ENDOPROSTHESIS

CAUTION: Investigational device. Limited by United States law to investigational use.

Apr 12, 2022

FIRST EUROPEAN IMPLANTS FOR THE GORE® EXCLUDER® THORACOABDOMINAL BRANCH ENDOPROSTHESIS PIVOTAL STUDY

Nov 23, 2021

Gore Announces First Commercial In-Human Use of GORE® TAG® Conformable Thoracic Stent Graft with ACTIVE CONTROL System for TEVAR in Australia

New delivery system provides controlled and predictable placement of Gore’s highly conformable and time-tested stent graft

FDA Approves GORE® CARDIOFORM Septal Occluder for PFO Closure to Prevent Recurrent Ischemic Stroke

Gore REDUCE Clinical Study demonstrated 77 percent relative reduction in recurrent ischemic stroke when PFO closure was combined with antiplatelet therapy, compared to antiplatelet therapy alone

Pagination

  • Load more

Residents of some states have the right to opt-out of the “sharing” or “selling” of their personal information. Gore does not "sell" the personal information of website users. Gore may "share" the personal information of website users, as standard advertising practice meant to offer you a more personalized service.

If you want to opt-out from Gore “sharing” your personal information, click on Opt-Out of Sharing to turn off the targeting cookies that we share with our advertising partners in order to provide you with personalized information. Disabling sharing will stop the use of cookies to targeted advertising but you may still see generic Gore ads.

Please note that your exercising of the rights outlined will have no adverse effect on the price and quality of our goods or services.

Opt-Out of Sharing

You Have Successfully Opted Out of the Sharing of Your Personal Information

Please note that if you clear your cookies and then use another device or browser, etc. your opt-out status is not transferred to the new device or browser.

  • Cookie Settings
  • Support
  • Legal Information
  • Privacy Notice
  • Regulatory Information
  • Trademarks
  • Newsletter
  • Modern Slavery Statement
  • gore.com

Copyright © 2002-2025 | W. L. Gore & Associates, Inc. | Products listed may not be available in all markets.